Randomized trial · people
CJC-1295 with DAC: one shot raised GH 2- to 10-fold in healthy adults
Checked against the paper Randomized trialPublished by PepVault
The takeaway
In healthy adults, a single CJC-1295 shot kept GH and IGF-I raised for days, and repeated doses kept IGF-I up for weeks, with no serious side effects reported.
- Kind
- Randomized trial
- Studied in
- People
- Published
- 2006
- Journal
- J Clin Endocrinol Metab
What they tested
The team tested how long CJC-1295, a long-acting form of the hormone GHRH, stays in the body, how it changes growth hormone (GH) and IGF-I levels, and how safe it is.
How the study was done
Two randomized, double-blind, placebo-controlled trials in healthy adults aged 21-61, run at two sites and lasting 28 and 49 days. Doses went up step by step: the first trial gave one of four single doses under the skin, and the second gave two or three doses weekly or every two weeks.

What they found
After one injection, average GH in the blood rose 2- to 10-fold for 6 days or more, and average IGF-I rose 1.5- to 3-fold for 9-11 days, with bigger rises at higher doses. CJC-1295 had an estimated half-life (the time for half of it to clear) of 5.8-8.1 days. With repeated doses, average IGF-I stayed above starting levels for up to 28 days, and the effect built up over doses. No serious side effects were reported, and the drug was fairly well tolerated, especially in the 30 and 60 microg/kg dose groups.
What it doesn’t show
Only healthy adults were studied, over 28 to 49 days, and the results are hormone levels in the blood rather than health or body changes. The trials tested increasing doses to check safety and drug levels, not long-term effects.
The paper
Teichman et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006.
The compound
More studies on CJC-1295 with DAC
- CJC-1295 with DAC changed serum protein patterns in healthy menClinical trial · people · 2009
- CJC-1295 with DAC: trough GH up 7.5-fold, pulses kept in healthy menClinical trial · people · 2006
- CJC-1295 with DAC daily normalized growth in GHRH knockout miceAnimal study · mice · 2006
- CJC-1295 with DAC: 4-fold larger GH response than hGRF(1-29) in ratsAnimal study · rats · 2005
- Every study on CJC-1295 with DAC
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.